Home › Blog › Weight Loss › Mounjaro Manchester

Mounjaro Manchester 2026: NHS vs Private, Prices From £139, Waiting Times and How to Get Started Today

Mounjaro in Manchester: The Essential Guide

Mounjaro (tirzepatide) is the UK’s most prescribed weight loss injection — producing an average of 22.5% body weight loss at 15mg over 72 weeks in the landmark SURMOUNT-1 trial. For patients in Manchester and Greater Manchester, access comes through two routes: NHS prescription via tier 3 specialist services (with significant waiting times), or private prescription through a GPhC-registered provider like Slinic with next-day delivery.

This guide covers everything a Manchester patient needs to know: NHS eligibility and waiting times in NHS Greater Manchester ICB, how to access private Mounjaro at fixed 2026 prices, eligibility criteria, dosing, and what to expect.

Obesity in Manchester: The Local Picture

Greater Manchester has an adult obesity rate of approximately 31% — significantly above the national average of 26%. The rate reflects the region’s economic geography: Manchester city centre and Trafford trend lower; Rochdale, Wigan, and Oldham have rates exceeding 35% in some areas. The overall burden on NHS Greater Manchester’s health system from obesity-related conditions is estimated at £380 million annually.

Greater Manchester has devolved health governance — NHS Greater Manchester ICB was formed from the merger of CCGs and has more autonomy than most English ICBs. This has produced some innovative approaches to obesity management including community weight management pilots.

How to Get Mounjaro in Manchester: Two Routes

NHS Mounjaro in Manchester: Current Status and Waiting Times

Private Mounjaro in Manchester: Slinic’s Fixed 2026 Prices

Slinic delivers MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain to Greater Manchester next day. Fixed 2026 prices — no subscription, no minimum term, no hidden fees.

Each pen contains 4 weekly doses. Prices verified June 2026. No subscription — order when ready.

Am I Eligible for Mounjaro in Manchester?

Eligibility for private Mounjaro at Slinic (the route available immediately, without NHS waiting lists) requires:

• BMI 30 or above — no qualifying condition needed
• BMI 27 or above with at least one qualifying condition: type 2 diabetes, hypertension, cardiovascular disease, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
• Age 18 or over
• No absolute contraindications — including no personal or family history of medullary thyroid carcinoma or MEN2; not pregnant or breastfeeding

What Slinic Includes for Manchester Patients

The NHS Bridge Strategy for Manchester Patients

For patients in Manchester who are on the NHS waiting list (or want to get on it) while also wanting to start treatment now, the bridge strategy makes clinical sense:

1. Ask your GP today for a tier 3 weight management referral — this starts the NHS clock
2. Start Mounjaro privately at Slinic — your medication arrives in 24–48 hours, you begin losing weight while you wait
3. When your NHS tier 3 place comes through (typically 12–18 (variable by district)+ months in Manchester) — transition to NHS supply, typically at the same dose you’re already on

Starting private treatment does not affect your NHS eligibility or waiting list position. Your Slinic clinician can provide a treatment summary for your NHS tier 3 team when the time comes. See our full NHS Mounjaro guide for more detail →

Mounjaro vs Wegovy for Manchester Patients

How to Get Started at Slinic — Manchester Patients

1. Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation
2. A registered Slinic prescriber reviews your assessment — typically within a few hours during working hours
3. If approved, your first Mounjaro or Wegovy pen is dispatched within 24 hours — cold-chain tracked delivery to your Manchester address
4. Your free monthly check-in is scheduled — weight progress, dose management, side effect review, all included

Frequently Asked Questions — Mounjaro in Manchester

Who Prescribes Mounjaro in Manchester — What to Verify

Searching “Mounjaro Manchester” returns dozens of providers. Here is what every Greater Manchester patient should verify before ordering from any private provider:

Mounjaro Results: What Manchester Patients Can Realistically Expect

The SURMOUNT-1 trial — 2,539 patients, 72 weeks — gives the most reliable picture. Here is what the data shows at each timepoint, translated into real numbers for a typical Greater Manchester patient:

Mounjaro vs Other Weight Loss Options in Greater Manchester

Mounjaro at 15mg produces weight loss comparable to gastric sleeve surgery — at a fraction of the cost, without the surgical risk, and without irreversible anatomical changes. For Greater Manchester patients, it represents the most effective pharmacological treatment available at any price.

Greater Manchester-Specific Context: Devolved Health and Obesity Strategy

Greater Manchester is unique in English healthcare: it has the most devolved health governance of any region, with NHS Greater Manchester ICB operating under a “devo health” model that gives the city-region significant control over its own healthcare commissioning. This has produced some distinctive approaches to obesity management:

• The Greater Manchester Obesity Strategy — GM has an integrated obesity strategy spanning NHS tier 1 through tier 3 services, public health campaigns, and community weight management. This is more coordinated than most English regions.
• Earlier NICE TA1026 implementation — NHS GM ICB was among the earlier English ICBs to begin implementing the Mounjaro tier 3 pathway after NICE TA1026 approval in June 2025.
• High demand pressure — with 31% obesity prevalence across 2.8 million people, demand significantly outpaces service capacity even with earlier implementation. Waiting times remain 12–18 months.
• QOF participation — the April 2026 QOF update means some Greater Manchester GP practices can now prescribe Mounjaro directly for qualifying patients with type 2 diabetes, without the tier 3 referral pathway. Ask your GP whether their practice participates.

Mounjaro Eligibility for Greater Manchester Patients

Eligibility for private Mounjaro at Slinic — the route available immediately without waiting lists:

The Mounjaro Dosing Schedule: Month by Month

Mounjaro Side Effects: A Practical Guide for Manchester Patients

The majority of Mounjaro side effects are gastrointestinal and temporary. Here is the complete picture from SURMOUNT-1 at 15mg, with practical management for each:

Mounjaro in Greater Manchester for Patients with Type 2 Diabetes

Greater Manchester has a significantly elevated rate of type 2 diabetes — partly driven by high obesity prevalence and partly reflecting the large South Asian communities in parts of the city-region where diabetes risk is higher at lower BMI. For Manchester patients with T2D, Mounjaro has particular relevance:

• Mounjaro is the only weight loss medication with a dual licence for both weight management AND type 2 diabetes in the UK
• In the SURPASS-2 trial, Mounjaro 15mg reduced HbA1c by an average of 2.58% — exceptional blood sugar control alongside weight loss
• The April 2026 QOF update means some Greater Manchester GP practices can now prescribe Mounjaro directly for T2D patients without a tier 3 referral — ask your GP if their practice participates in the new QOF obesity indicators
• If you are already on Mounjaro privately through Slinic for weight management and have T2D, tell your Slinic prescriber — dose management may differ and coordination with your GP’s diabetes management is important

NHS Bridge Strategy for Greater Manchester Patients

Given NHS Greater Manchester’s typical 12–18 month waiting time for tier 3 weight management services, a two-track approach makes sense for many patients:

1. Ask your GP today for a tier 3 weight management referral — this starts the NHS clock. Ask specifically about the current waiting time for your specific district (see the district table above).
2. Start Mounjaro privately at Slinic immediately — assessment to delivery in 24–48 hours, at fixed 2026 prices. Begin losing weight now.
3. When your NHS tier 3 appointment comes (typically 12–18 months in Greater Manchester) — you will have already achieved significant weight loss with Slinic. The tier 3 team takes over your care. Your Slinic monthly check-in notes provide a clear treatment history.

This approach is clinically rational: you lose 12–18 months of potential treatment by waiting for NHS access. Starting privately now and transitioning to NHS later costs you no more than waiting — and produces results 12–18 months sooner.

How Slinic Delivers to Greater Manchester

Slinic dispatches all orders within 24 hours of prescription approval, via next-day tracked cold-chain courier to every Greater Manchester postcode. Deliveries reach all 10 GM districts:

• Manchester city centre (M1–M4, M11–M16)
• Salford (M5–M7, M50)
• Trafford (M17, M32–M33, WA14–WA15)
• Stockport (SK1–SK8)
• Tameside (OL5–OL7, SK14–SK16)
• Oldham (OL1–OL4, OL8–OL9)
• Rochdale (OL10–OL12, OL16)
• Bury (BL8–BL9)
• Bolton (BL1–BL7)
• Wigan (WN1–WN8)

Cold-chain packaging maintains 2–8°C throughout transit regardless of outside temperature. Slinic uses specialist pharmaceutical cold-chain couriers — not standard parcel services. Your medication arrives in the same condition as it left our dispensary.

References and Further Reading

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
2. NICE TA1026 — Tirzepatide for managing overweight and obesity. 2025. nice.org.uk/guidance/ta1026
3. NICE TA875 — Semaglutide for managing overweight and obesity. 2023.
4. NHS Greater Manchester ICB. NHS commissioning guidance for weight management medications. June 2026.
5. GPhC. Guidance for registered pharmacies providing services at a distance. February 2025. pharmacyregulation.org
6. Health Survey for England 2024 / Scottish Health Survey 2024. Adult obesity statistics.

Related Guides